Kazuki Nagasawa Selected Research

sodium-nucleoside cotransporter

8/2006	Cytidine is a novel substrate for wild-type concentrative nucleoside transporter 2.
6/2003	Pirarubicin is taken up by a uridine-transportable sodium-dependent concentrative nucleoside transporter in Ehrlich ascites carcinoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazuki Nagasawa Research Topics

Disease

4	Sarcoma (Soft Tissue Sarcoma) 08/2006 - 03/2002
3	Neoplasms (Cancer) 12/2017 - 03/2007
3	Inflammation (Inflammations) 01/2017 - 10/2003
3	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2008 - 02/2005
2	Colitis 01/2022 - 01/2017
2	Colorectal Neoplasms (Colorectal Cancer) 08/2018 - 12/2017
2	Taste Disorders (Taste Disorder) 01/2017 - 01/2016
2	Ischemia 12/2011 - 04/2010
2	Ascites 06/2003 - 03/2002
2	Carcinoma (Carcinomatosis) 06/2003 - 03/2002
1	Down Syndrome (Down's Syndrome) 01/2019
1	Peripheral Nervous System Diseases (PNS Diseases) 08/2018
1	Hyperalgesia 08/2018
1	Cardiotoxicity 12/2017
1	Hand-Foot Syndrome 12/2017
1	Gliosis 12/2017
1	Multiple Myeloma 01/2017
1	Colonic Neoplasms (Colon Cancer) 01/2016
1	Dizziness (Lightheadedness) 01/2015
1	Sleepiness 01/2015
1	Neuralgia (Stump Neuralgia) 01/2015
1	Mitochondrial Diseases (Mitochondrial Disease) 09/2012
1	Wounds and Injuries (Trauma) 04/2010
1	Brain Ischemia (Cerebral Ischemia) 05/2008
1	Infections 05/2008
1	Nervous System Diseases (Neurological Disorders) 05/2008
1	Neuroblastoma 05/2006
1	Alzheimer Disease (Alzheimer's Disease) 09/2004
1	Hyperoxia 08/2003
1	Astrocytoma (Pilocytic Astrocytoma) 08/2003

Drug/Important Bio-Agent (IBA)

3	Oxaliplatin (Eloxatin)FDA LinkGeneric 08/2018 - 01/2016
3	Pharmaceutical PreparationsIBA 08/2018 - 03/2002
3	ZincIBA 12/2017 - 05/2008
3	Purinergic P2X7 ReceptorsIBA 01/2017 - 09/2012
3	SodiumIBA 02/2006 - 06/2003
3	pirarubicinIBA 03/2005 - 03/2002
2	Dextran SulfateIBA 01/2022 - 01/2017
2	SolutionsIBA 01/2022 - 01/2017
2	CationsIBA 08/2018 - 01/2017
2	sodium-nucleoside cotransporterIBA 08/2006 - 06/2003
2	AluminumIBA 05/2006 - 02/2005
2	AnthracyclinesIBA 02/2006 - 03/2005
2	NucleosidesIBA 02/2006 - 03/2005
2	Nucleoside Transport Proteins (Nucleoside Transporter)IBA 02/2006 - 06/2003
2	Proteins (Proteins, Gene)FDA Link 09/2004 - 08/2003
2	Type C PhospholipasesIBA 09/2004 - 08/2003
1	CopperIBA 01/2019
1	ErgothioneineIBA 08/2018
1	Carnitine (L-Carnitine)FDA LinkGeneric 08/2018
1	PlatinumIBA 08/2018
1	liposomal doxorubicin (Doxil)FDA Link 12/2017
1	Liposomes (Liposome)IBA 12/2017
1	Purinergic Receptors (Receptors, Purine)IBA 01/2017
1	Magnesium Chloride FDA LinkGeneric 01/2017
1	Proteasome InhibitorsIBA 01/2017
1	MetalsIBA 01/2017
1	MineralsIBA 01/2017
1	Bortezomib (Velcade)FDA Link 01/2017
1	MagnesiumIBA 01/2017
1	Opioid Analgesics (Opioids)IBA 01/2015
1	Pregabalin (Lyrica)FDA Link 01/2015
1	Analgesics (Analgesic Drugs)IBA 01/2015
1	Adenosine Triphosphate (ATP)IBA 09/2012
1	NADPH Oxidases (NAD(P)H oxidase)IBA 12/2011
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2011
1	EnzymesIBA 04/2010
1	NAD (NADH)IBA 04/2010
1	Poly (ADP-Ribose) Polymerase-1IBA 04/2010
1	A-Form DNA (A-DNA)IBA 04/2010
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2008
1	Chelating AgentsIBA 05/2008
1	Matrix Metalloproteinases (MMPs)IBA 05/2008
1	Fluorouracil (Carac)FDA LinkGeneric 03/2007
1	AntimetabolitesIBA 03/2007
1	Thioguanine (Tioguanine)FDA Link 03/2007
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 03/2007
1	CytidineIBA 08/2006
1	Peptides (Polypeptides)IBA 08/2006
1	aluminum citrateIBA 05/2006
1	Citric Acid (Citrate)FDA LinkGeneric 05/2006
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 09/2004
1	N-Methylaspartate (NMDA)IBA 09/2004
1	Morphine (MS Contin)FDA LinkGeneric 10/2003
1	IsoenzymesIBA 08/2003
1	AcrylonitrileIBA 08/2003
1	3-hydroxy-5-estrane-17-carbonitrile (ACN)IBA 08/2003
1	UridineIBA 06/2003
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2002

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2017 - 03/2007
1	Oral Administration 01/2017
1	Therapeutics 01/2017